Pharmarise 

¥507
5
+¥4+0.8% 06:30 Today

Statistics

Day High
507
Day Low
501
52W High
558
52W Low
471
Volume
6,100
Avg. Volume
7,882
Mkt Cap
6.11B
P/E Ratio
17.97
Dividend Yield
2.78%
Dividend
14.11

Upcoming

Dividends

2.78%Dividend Yield
Aug 26
¥14
Aug 25
¥14
Aug 24
¥6
Aug 24
¥14
Aug 23
¥14
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

17SepExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-13.91
-4.65
4.6
13.86
Expected EPS
N/A
Actual EPS
N/A

Financials

-0.58%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
63.51BRevenue
-367MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2796.TSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Ono Pharmaceutical
4528.TSE
Mkt Cap1.65T
Ono Pharmaceutical Co., Ltd. - Competes in the pharmaceutical sector with a focus on developing and marketing drugs, similar to Pharmarise's operations.
Astellas Pharma
4503.TSE
Mkt Cap3.68T
Astellas Pharma Inc. - A major player in the pharmaceutical industry, offering products that could compete with Pharmarise's offerings.
Shionogi &.
4507.TSE
Mkt Cap2.12T
Shionogi & Co., Ltd. - Engages in the research, development, manufacturing, and marketing of pharmaceuticals, directly competing with Pharmarise.
Chugai Pharmaceutical
4519.TSE
Mkt Cap6.03T
Chugai Pharmaceutical Co., Ltd. - Specializes in biopharmaceuticals, posing competition to Pharmarise in the specialty pharmaceutical market.
Daiichi Sankyo.
4568.TSE
Mkt Cap8.21T
Daiichi Sankyo Company, Limited - A global pharmaceutical company that competes with Pharmarise in the development and marketing of pharmaceutical products.
Kyowa Kirin.
4151.TSE
Mkt Cap1.75T
Kyowa Kirin Co., Ltd. - Focuses on pharmaceuticals and biotechnologies, competing with Pharmarise in both domestic and international markets.
Takeda Pharmaceutical
4502.TSE
Mkt Cap6.05T
Takeda Pharmaceutical Company Limited - As a leading global pharmaceutical company, it competes across many of the same therapeutic areas as Pharmarise.
Sumitomo Pharma.
4506.TSE
Mkt Cap419.94B
Sumitomo Pharma Co., Ltd. - Offers pharmaceutical products that compete with Pharmarise's range, especially in the Japanese market.
OtsukaLtd.
4578.TSE
Mkt Cap2.43T
Otsuka Holdings Co., Ltd. - Competes with Pharmarise through its diverse portfolio of pharmaceutical products in various therapeutic categories.
Nippon Shinyaku.
4516.TSE
Mkt Cap517.95B
Nippon Shinyaku Co., Ltd. - Competes in the pharmaceutical industry by focusing on the development and marketing of unique pharmaceutical products, similar to Pharmarise's strategy.

About

Pharmarise Holdings Corporation predominantly oversees a chain of pharmacies that dispense prescription medications throughout Japan. These establishments fulfill prescriptions provided by medical facilities, offering vital pharmaceutical services to patients. Beyond its primary dispensing activities, the company also manages drugstores and convenience stores, and retails cosmetic products. Additionally, it provides services including the safekeeping and administration of patient medical records for healthcare institutions, operates medical complex centers, and offers temporary staffing assistance. As of May 31, 2021, the corporation maintained a network of 347 outlets. Pharmarise Holdings Corporation was founded in 1984 and its main office is located in Tokyo, Japan.
Show more...
CEO
Masayuki Akiyama
Employees
2031
Country
Japan
ISIN
JP3802320006

Listings

0 Comments

Share your thoughts

FAQ

What is Pharmarise stock price today?
The current price of 2796.TSE is ¥507 JPY — it has increased by +0.8% in the past 24 hours. Watch Pharmarise stock price performance more closely on the chart.
What is Pharmarise stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Tokyo Stock Exchange exchange Pharmarise stocks are traded under the ticker 2796.TSE.
Is Pharmarise stock price growing?
2796.TSE stock has risen by +0.4% compared to the previous week, the month change is a +3.26% rise, over the last year Pharmarise has showed a +0.6% increase.
What is Pharmarise market cap?
Today Pharmarise has the market capitalization of 6.11B
When is the next Pharmarise earnings date?
Pharmarise is going to release the next earnings report on September 17, 2026.
What were Pharmarise earnings last quarter?
2796.TSE earnings for the last quarter are -13.65 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Pharmarise revenue for the last year?
Pharmarise revenue for the last year amounts to 63.51B JPY.
What is Pharmarise net income for the last year?
2796.TSE net income for the last year is -367M JPY.
Does Pharmarise pay dividends?
Yes, 2796.TSE dividends are paid annual. The last dividend per share was 14 JPY. As of today, Dividend Yield (FWD)% is 2.78%.
How many employees does Pharmarise have?
As of September 09, 2026, the company has 2,031 employees.
In which sector is Pharmarise located?
Pharmarise operates in the Health & Wellness sector.
When did Pharmarise complete a stock split?
The last stock split for Pharmarise was on November 27, 2013 with a ratio of 100:1.
Where is Pharmarise headquartered?
Pharmarise is headquartered in Tokyo, Japan.